Associate Professor Dr Tan Kit Mun is a senior consultant geriatrician in the University of Malaya Medical Centre (UMMC). She received her medical degree from Trinity College, (MB. BCh. II Hons) University of Dublin, Ireland in 1999. Dr. Tan is a fellow of the Royal College of Physicians Edinburgh (FRCP) UK. She completed her specialist training and received her Certificate of Satisfactory Completion of Specialist Training (CSCST) in Geriatric Medicine from the Irish Committee of Higher Medical Training, Royal College of Physicians Ireland in 2009. She was practising as a consultant geriatrician in Dublin, Ireland until 2012. Dr. Tan's special interest include stroke, atrial fibrillation, dementia, osteoporosis, hypertension in the older person and comprehensive geriatric assessment of the complex older person. Dr. Tan is also an Assoiciate Professor with the Faculty of Medicine, University of Malaya. She is a trainer for the Malaysian Geriatric Medicine Specialist Training Scheme, Masters of Internal Medicine Programme in University of Malaya as well as the University of Malaya Medical Programme (UMMP). She is a member of the Malaysian Society of Geriatric Medicine (MSGM) and participates as a speaker and presenter of research findings at the annual Malaysian Congress of Geriatric Medicine (MCGM).  

Associate Professor Dr. Chen Yeng is an expert in cancer biomarker discovery, biosensor development, and natural therapeutics, with a multidisciplinary approach that bridges nanotechnology, molecular biology, and biomedicine. Her expertise is particularly evident in her work on innovative diagnostic technologies and personalized therapeutic solutions, targeting both cancer and infectious diseases. Her research interests span several cutting-edge areas. One of her primary focuses is the identification and characterization of cancer biomarkers, particularly through novel approaches targeting at immunogenic host proteins. This line of research explores how immunogenic proteins’ interventions might modulate cancer risk, representing an innovative intersection of microbiology, proteomics, and oncology. Dr. Chen is also deeply engaged in developing advanced diagnostic tools, including nanobiosensors with enhanced sensitivity and specificity. These devices, designed to detect critical biomarkers such as those associated with tuberculosis, blood clotting disorders, and oral cancer, are transformative for early disease detection. Her work in biosensors, utilizing materials like gold nanoparticles and zinc oxide nanolayers, has set new standards in diagnostic accuracy and reliability. Another cornerstone of her research is the study of natural plant extracts for therapeutic applications, particularly in cancer treatment. She investigates the biochemical and pharmacological properties of these extracts, focusing on their mechanisms of action, such as inducing apoptosis, causing cell cycle arrest, and promoting mitochondrial dysfunction in cancer cells. Her exploration of natural products' roles in modulating microRNAs further highlights her innovative approach to cancer research. Dr. Chen’s expertise also extends to the antioxidant, hepatoprotective, and genoprotective properties of herbal compounds, offering potential preventive and therapeutic solutions for chronic diseases. These studies underline her commitment to sustainable and natural approaches in healthcare. Her contributions to genomics and proteomics, particularly in large-scale screening for biological markers, further demonstrate her role as a leader in translating complex biological data into meaningful clinical applications. By combining her deep understanding of molecular biology with a focus on real-world impact, Dr. Chen has established herself as a pioneer in her field. Dr. Chen’s academic influence is demonstrated by her impressive h-index of 28 (ResearchID) and 39 (Scopus), with over 4,500 citations to her name. Her extensive publication record spans high-impact journals, contributing significantly to advancements in dentistry, oncology, and biomedical engineering. She is recognized as a top scientist in Malaysia, ranking among the leading figures in dentistry according to the AD Scientific Index.As a respected peer reviewer for prestigious journals, including Coordination Chemistry Reviews, Periodontal 2000, Biosensors and Bioelectronics, and Cancer Letters, Dr. Chen plays a critical role in maintaining the quality of research within her fields of expertise. Her contributions extend to academic leadership, where she had supervised and graduated over 20 postgraduate students, including 12 PhD candidates, nurturing the next generation of scientific leaders.Her leadership in dental education accreditation has further solidified her impact on academic excellence. She has played pivotal roles in the reaccreditation of dental programs at the University of Malaya and other institutions, ensuring that these programs meet global standards.Through her commitment to interdisciplinary collaboration, Dr. Chen has partnered with industry leaders to translate research findings into practical healthcare solutions, such as rapid diagnostic tools and personalized treatments. These collaborations exemplify her ability to bridge scientific discovery with real-world applications.In summary, Dr. Chen’s expertise and research interests reflect a holistic approach to biomedical science, integrating cutting-edge technologies with sustainable practices. Her work not only pushes the boundaries of knowledge in cancer research and diagnostics but also has the potential to transform patient care and public health globally.  

Mohammad Khairi Mokthar is currently a Senior Lecturer at the Dance Department of the Faculty of Creative Arts at Universiti Malaya. He completed his doctoral studies at Universiti Malaya, specializing in ethnography with a focus on Terinai, a traditional Malay Classical Dance of Perlis. He holds a Master of Fine Arts in Dance Performance, with a major in contemporary dance, from Korea National University of Arts, (K'ARTS) Korea, where he was awarded a scholarship by the Korea Ministry of Culture, Sports, and Tourism. His dance journey began during his teenage years when he was exposed to Malay traditional dance. He pursued his tertiary dance education at the National Academy of Arts, Culture, and Heritage (ASWARA), Malaysia, where he received formal training in various dance forms, including Malay classical and folk dance, Chinese folk dance, ethnic dance, and Indian classical dance. He completed his Diploma in Dance in 2010 and his Bachelor of Dance (Performance) in 2013 at ASWARA. In 2013, he made his debut as an Indian classical dancer with a Bharatanatyam Arangetram. He has also worked professionally, including as a principal dancer at ASK Dance Company and in England with the Shobana Jeyasingh Dance for the Classic Cut Tour in 2012 and 2013. He has received numerous awards and recognitions for his contributions to dance, including Best Choreographer in Full-length Work at the 12th BOH Cameronian Arts Awards Malaysia in 2015, 2nd prize in the Seoul International Dance Competition in 2015 and 2016, and being named one of the Top 10 New Generation Malaysian Cultural Dancers in 2017. In addition to his performance work, Mohammad Khairi Mokthar has also served as a part-time lecturer and coach at various institutions, including Sultan Idris Education University (UPSI) and ASWARA. He received The Shining Star Awards in 2019, organized by the Uniques Arts Culture and Heritage Foundation in collaboration with the Ministry of Tourism, Arts, and Culture Malaysia. In 2019, he collaborated with choreographer Mavin Khoo and TFA Inner Space Dance Company for a performance titled "I am Ravana" at Sadler's Wells in London. He is recognized as an educator, choreographer, dancer, and scholar in the field of dance.